Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow-derived mesenchymal stem cells to prevent GVHD after HSCT
CTR20132698Phase 2Completed
- Sponsor
- Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
- Start
- Mar 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow-derived mesenchymal stem cells in hematopoietic malignancies, graft-versus-host disease (GVHD), sponsored by Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. Started Mar 2014; status: completed.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
hematopoietic malignanciesgraft-versus-host disease (GVHD)
Beyond the preview
Go deeper on CTR20132698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132698.